Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy
Open accessThe DOI matches its Crossref record.
Abstract
Paraneoplastic retinopathies (PR), including cancer-associated retinopathy (CAR) or the closely related melanoma-associated retinopathy (MAR) occur in a small subset of patients with retinal degeneration and systemic cancer. This autoimmune syndrome is characterized by sudden, progressive loss of vision in association with circulating anti-retinal autoantibodies. The PR syndromes are heterogeneous, may produce a number of ocular symptoms, and may be associated with several different neoplasms, including lung, breast, prostate, gynecological, and colon cancer, melanoma, and hematologic malignancies. We examined the onset of retinopathy in correlation to the diagnosis of cancer and the presence of specific anti-retinal autoantibodies in PR patients. In some patients without diagnosed malignant tumors, the onset of ocular symptoms and the presence of autoantibodies preceded the diagnosis of cancer by months to years, including anti-recoverin, anti-transducin-α, and anti-carbonic anhydrase II antibodies. Although anti-retinal autoantibodies may not be a good predictor of a specific neoplasm, they can be used as biomarkers for different subtypes of retinopathy. Identification of autoantibodies involved in autoimmune-mediated PR will help elucidate the mechanisms underlying the PR syndromes and develop targeted therapies for these sight-threatening disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
van Dijk, E. H. C., van Herpen, C. M. L., Marinkovic, M., Haanen, J. B. A. G., Amundson, D., Luyten, G. P. M., Jager, M. J., Kapiteijn, E. H. W., Keunen, J. E. E., Adamus, G., et al. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.05.027 · Cited by 79
Self-citationUnilateral cancer-associated retinopathy: diagnosis, serology and treatment
Roels, D., Ueno, S., Talianu, C. D., Draganova, D., Kondo, M., & Leroy, B. P. (2017) · Documenta Ophthalmologica · doi:10.1007/s10633-017-9605-y · Cited by 35
Adamus, G. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.672444 · Cited by 16
Self-citation
Metadata
- Authors
- Adamus, G.
- Venue
- Autoimmunity Reviews
- Publisher
- Elsevier BV
- Published
- 2009-03
- Volume
- 8
- Issue
- 5
- Pages
- 410-414
- ISSN
- 1568-9972 (ISSN-L)
- OpenAlex
- W2041557956
- Cited by
- 216
- References
- 0
- FWCI
- 6.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy. https://app.cochat.ai/papers/10.1016/j.autrev.2009.01.002
- The paper
- Adamus, G. (2009). Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy. Autoimmunity Reviews. https://doi.org/10.1016/j.autrev.2009.01.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.